fundoplication; Nissen fundoplication; Collis gastroplasty

^[1]^[2]^[3]^[4]

Indications

dysphagia (19%)
flatulence (5-8%)
bloating (5-8%)
esophageal dilation (6%)
redo-fundoplication (2%)
- 18% experience reflux recurrence^[3]
mortality 0.8% (30 days)
sustained use of gastrointestinal agents
- proton-pump inhibitors (34%)
- H2-receptor antagonists (24%)
- promotility agents (9%)
30-day postoperative complications (8%)^[3]

Collis gastropathy when performed is generally performed in association with fundoplication

↑ Dominitz JA, Dire CA, Billingsley KG, Todd-Stenberg JA. Complications and antireflux medication use after antireflux surgery. Clin Gastroenterol Hepatol. 2006 Mar;4(3):299-305. PMID: https://www.ncbi.nlm.nih.gov/pubmed/16527692
↑ Spechler SJ, Lee E, Ahnen D, Goyal RK, Hirano I, Ramirez F, Raufman JP, Sampliner R, Schnell T, Sontag S, Vlahcevic ZR, Young R, Williford W. Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial. JAMA. 2001 May 9;285(18):2331-8. PMID: https://www.ncbi.nlm.nih.gov/pubmed/11343480
Kahrilas PJ. Surgical therapy for reflux disease. JAMA. 2001 May 9;285(18):2376-8. No abstract available. PMID: https://www.ncbi.nlm.nih.gov/pubmed/11343486
↑ ^3.0 ^3.1 ^3.2 ^3.3 Maret-Ouda J, Wahlin K, El-Serag HB et al Association Between Laparoscopic Antireflux Surgery and Recurrence of Gastroesophageal Reflux. JAMA. 2017;318(10):939-946 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/28898377 <Internet> http://jamanetwork.com/journals/jama/article-abstract/2653734
Spechler SJ. The Durability of Antireflux Surgery. JAMA. 2017 Sep 12;318(10):913-915. <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/28898363 <Internet> http://jamanetwork.com/journals/jama/article-abstract/2653718
↑ The Esophagogastric Junction: Surgical treatments When should a Collis gastroplasty be performed? http://www.hon.ch/OESO/free/Vol_5_Eso_Junction/Articles/art243.html